Search Results

You are looking at 1 - 10 of 10 items for :

  • "Reference range" x
  • Hyperthyroidism and thyrotoxicosis x
Clear All
Yiyun Cui Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Yiyun Cui in
Google Scholar
PubMed
Close
,
Jinlong Chen Department of Cardiology, Children's Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Jinlong Chen in
Google Scholar
PubMed
Close
,
Rui Guo Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Rui Guo in
Google Scholar
PubMed
Close
,
Ruize Yang Department of Public Health, Children's Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Ruize Yang in
Google Scholar
PubMed
Close
,
Dandan Chen Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Dandan Chen in
Google Scholar
PubMed
Close
,
Wei Gu Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Wei Gu in
Google Scholar
PubMed
Close
,
Francis Manyori Bigambo School of Public Health, Nanjing Medical University, Nanjing, China

Search for other papers by Francis Manyori Bigambo in
Google Scholar
PubMed
Close
, and
Xu Wang Department of Endocrinology, Children's Hospital of Nanjing Medical University, Nanjing, China

Search for other papers by Xu Wang in
Google Scholar
PubMed
Close

remission and relapse groups on admission. Reference ranges Remission group ( n  = 39) Relapse group ( n  = 40) P ALT (U/L) 5–40 25.00 (19.00–37.00) 28.50 (21.75–37.50) 0.50 AST (U/L) 5–40 25.00 (20

Open access
Claire L Wood Department of Paediatric Endocrinology, Great North Children’s Hospital, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK

Search for other papers by Claire L Wood in
Google Scholar
PubMed
Close
,
Niamh Morrison Department of Paediatric Endocrinology, Great North Children’s Hospital, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK

Search for other papers by Niamh Morrison in
Google Scholar
PubMed
Close
,
Michael Cole Population Health Sciences Institute, Newcastle University, Baddiley-Clark Building, Newcastle upon Tyne, UK

Search for other papers by Michael Cole in
Google Scholar
PubMed
Close
,
Malcolm Donaldson Department of Child Health, University of Glasgow School of Medicine, Glasgow, UK

Search for other papers by Malcolm Donaldson in
Google Scholar
PubMed
Close
,
David B Dunger Department of Paediatrics, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK
Wellcome Trust-MRC Institute of Metabolic Sciences, University of Cambridge, Cambridge, UK

Search for other papers by David B Dunger in
Google Scholar
PubMed
Close
,
Ruth Wood Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, UK

Search for other papers by Ruth Wood in
Google Scholar
PubMed
Close
,
Simon H S Pearce Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK
Department of Endocrinology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK

Search for other papers by Simon H S Pearce in
Google Scholar
PubMed
Close
, and
Timothy D Cheetham Department of Paediatric Endocrinology, Great North Children’s Hospital, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK
Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, International Centre for Life, Central Parkway, Newcastle upon Tyne, UK

Search for other papers by Timothy D Cheetham in
Google Scholar
PubMed
Close
on behalf of the British Society for Paediatric Endocrinology and Diabetes (BSPED)

thyroxine (FT4) response in the two groups; specifically the time taken for TSH levels to rise or for FT4 concentrations to fall within the local reference ranges. Free tri-iodothyroinine (FT3) concentrations were not measured routinely in this trial

Open access
Mats Holmberg ANOVA, Karolinska University Hospital, Norra Stationsgatan 69, Stockholm, Sweden
Institute of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden

Search for other papers by Mats Holmberg in
Google Scholar
PubMed
Close
,
Helge Malmgren Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Helge Malmgren in
Google Scholar
PubMed
Close
,
Peter F Berglund Institute of Neuroscience and Physiology, Department of Clinical Neuroscience, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Peter F Berglund in
Google Scholar
PubMed
Close
,
Birgitta Johansson Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden

Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Close
, and
Helena Filipsson Nyström Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden
Gothenburg Centre for Person Centred-Care (GPCC), Göteborg, Sweden

Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
Close

Hospital, Göteborg ( n  = 64) and from the Department of Medicine at Kungälv’s Hospital, Kungälv ( n  = 1) in Sweden. They were eligible for the study if they were premenopausal, with fT4 levels ≥50 pmol/L (reference range: 12–22) and/or total T3 ≥6.0 nmol

Open access
Alessandro Brancatella Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Alessandro Brancatella in
Google Scholar
PubMed
Close
,
Laura Pierotti Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Laura Pierotti in
Google Scholar
PubMed
Close
,
Nicola Viola Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Nicola Viola in
Google Scholar
PubMed
Close
,
Isabella Lupi Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Isabella Lupi in
Google Scholar
PubMed
Close
,
Lucia Montanelli Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Lucia Montanelli in
Google Scholar
PubMed
Close
,
Chiara Cremolini Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

Search for other papers by Chiara Cremolini in
Google Scholar
PubMed
Close
,
Paolo Piaggi Department of Information Engineering, University of Pisa, Pisa, Italy

Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Close
,
Antonio Chella Pneumology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy

Search for other papers by Antonio Chella in
Google Scholar
PubMed
Close
,
Andrea Antonuzzo Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy

Search for other papers by Andrea Antonuzzo in
Google Scholar
PubMed
Close
,
Daniele Sgrò Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Daniele Sgrò in
Google Scholar
PubMed
Close
,
Lucia Antonangeli Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Lucia Antonangeli in
Google Scholar
PubMed
Close
,
Chiara Sardella Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Chiara Sardella in
Google Scholar
PubMed
Close
,
Sandra Brogioni Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Close
,
Claudio Marcocci Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Close
,
Ferruccio Santini Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Ferruccio Santini in
Google Scholar
PubMed
Close
, and
Francesco Latrofa Endocrinology Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy

Search for other papers by Francesco Latrofa in
Google Scholar
PubMed
Close

). Reference ranges were 8–18 ng/dL for FT4, 2.5–5.0 ng/L for FT3 and 0.4–4 mIU/L for TSH. Tg was measured by an immunometric assay (Access Thyroglobulin assay; Beckman Coulter, Inc., Fullerton, CA, USA) (functional sensitivity 0.1 ng/mL). TgAbs were measured

Open access
J Karmisholt Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Institute, Aalborg University, Aalborg, Denmark

Search for other papers by J Karmisholt in
Google Scholar
PubMed
Close
,
S L Andersen Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by S L Andersen in
Google Scholar
PubMed
Close
,
I Bulow-Pedersen Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Institute, Aalborg University, Aalborg, Denmark

Search for other papers by I Bulow-Pedersen in
Google Scholar
PubMed
Close
,
A Krejbjerg Department of Oncology, Aalborg University Hospital, Aalborg, Denmark

Search for other papers by A Krejbjerg in
Google Scholar
PubMed
Close
,
B Nygaard Department of Endocrinology and Internal Medicine, Herlev University Hospital, Copenhagen, Denmark

Search for other papers by B Nygaard in
Google Scholar
PubMed
Close
, and
A Carlé Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Department of Clinical Institute, Aalborg University, Aalborg, Denmark

Search for other papers by A Carlé in
Google Scholar
PubMed
Close

, agranulocytosis, and liver failure. Thyroid hormone and antibody assays Serum total T3 (reference range: Aalborg 1.1–2.5 nmol/L, Copenhagen 1.0–2.6 nmol/L), and TSH (reference range: Aalborg 0.30–4.5mU/L, Copenhagen 0.40–4.0 mU/L) were measured by automatic

Open access
Birgitta Johansson Department of Clinical Neuroscience, Sahlgrenska Academy, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Close
,
Mats Holmberg ANOVA, Karolinska University Hospital, Norra Stationsgatan 69, Stockholm, Sweden
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden

Search for other papers by Mats Holmberg in
Google Scholar
PubMed
Close
,
Simon Skau Department of Clinical Neuroscience, Sahlgrenska Academy, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
Department of Pedagogical, Curricular and Professional Studies, Faculty of Education, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Simon Skau in
Google Scholar
PubMed
Close
,
Helge Malmgren Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Search for other papers by Helge Malmgren in
Google Scholar
PubMed
Close
, and
Helena Filipsson Nyström Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
Close

was 4.0 months. Inclusion criteria were as follows: (i) premenopausal, (ii) free thyroxine ≥ 50 pmol/L (reference range 12–22) and/or total triiodothyronine ≥ 6.0 pmol/L (reference range 1.3–3.1), and (iii) positive thyroid-stimulating hormone

Open access
Ringo Manta Department of Nuclear Medicine, CHU Saint Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium

Search for other papers by Ringo Manta in
Google Scholar
PubMed
Close
,
Charlotte Martin Department of Infectious Diseases, CHU Saint Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium

Search for other papers by Charlotte Martin in
Google Scholar
PubMed
Close
,
Vinciane Muls Department of Gastroenterology and Endoscopy, CHU Saint-Pierre, University Libre de Bruxelles (ULB), Brussels, Belgium

Search for other papers by Vinciane Muls in
Google Scholar
PubMed
Close
, and
Kris G Poppe Department of Endocrinology, CHU Saint Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium

Search for other papers by Kris G Poppe in
Google Scholar
PubMed
Close

Reference range Year 2020 Year 2021 March 23 April 7 April 9 June 22 August 5 December 7 February 2 March 18 a April 12 April 14 April 27 Thyrotropin (mIU/L) 0.27–4.20 5.42 7.36 2.86 1.35 3.21 2/29 1

Open access
Georgios Kostopoulos Department of Endocrinology and Metabolism, Ippokratio General Hospital of Thessaloniki, Greece

Search for other papers by Georgios Kostopoulos in
Google Scholar
PubMed
Close
and
Grigoris Effraimidis Department of Endocrinology and Metabolic Diseases, Larissa University Hospital, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece

Search for other papers by Grigoris Effraimidis in
Google Scholar
PubMed
Close

subclinical hyperthyroidism and FT4 within the normal reference range. Study Year Country Design Subjects, n Age, years FU, years Thyroid function AF, % Risk (95% CI) Overt hyperthyroidism  Selmer

Open access
Sébastien Verdickt Department of Endocrinology, University Hospitals of Leuven, Leuven, Belgium

Search for other papers by Sébastien Verdickt in
Google Scholar
PubMed
Close
,
Falco Van Nes Department of Endocrinology, University Hospitals of Leuven, Leuven, Belgium

Search for other papers by Falco Van Nes in
Google Scholar
PubMed
Close
,
Carolien Moyson Department of Endocrinology, University Hospitals of Leuven, Leuven, Belgium

Search for other papers by Carolien Moyson in
Google Scholar
PubMed
Close
,
Toon Maes Department of Endocrinology, Imeldaziekenhuis Bonheiden, Bonheiden, Belgium

Search for other papers by Toon Maes in
Google Scholar
PubMed
Close
,
Paul Van Crombrugge Department of Endocrinology, OLV Ziekenhuis Aalst-Asse-Ninove, Aalst, Belgium

Search for other papers by Paul Van Crombrugge in
Google Scholar
PubMed
Close
,
Annick Van den Bruel Department of Endocrinology, AZ Sint Jan Brugge, Brugge, Belgium

Search for other papers by Annick Van den Bruel in
Google Scholar
PubMed
Close
, and
Brigitte Decallonne Department of Endocrinology, University Hospitals of Leuven, Leuven, Belgium

Search for other papers by Brigitte Decallonne in
Google Scholar
PubMed
Close

euthyroidism defined as TSH and fT4 within the normal reference range in a patient not synchronously treated with ATDs or L-T4. Hyperthyroidism was defined as either not meeting the criteria of cure or having undergone thyroid surgery or having received a

Open access
Meihua Jin Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine and School of Medicine, Seoul, Republic of Korea

Search for other papers by Meihua Jin in
Google Scholar
PubMed
Close
,
Ahreum Jang Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
Division of Endocrinology and Metabolism, Department Internal Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea

Search for other papers by Ahreum Jang in
Google Scholar
PubMed
Close
,
Chae A Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Chae A Kim in
Google Scholar
PubMed
Close
,
Tae Yong Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Tae Yong Kim in
Google Scholar
PubMed
Close
,
Won Bae Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Won Bae Kim in
Google Scholar
PubMed
Close
,
Young Kee Shong Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Close
,
Min Ji Jeon Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Close
, and
Won Gu Kim Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Close

measured by RIA using T3-CTK (DiaSorin SpA). The reference ranges of TSH, fT4, and total T3 were 0.4–4.5 mIU/L, 0.80–1.90 ng/dL, and 151–277 ng/dL, respectively. TRAb was measured using a competitive TSH-binding inhibitory immunoglobulin (TBII) assay by the

Open access